Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Tumor Biology 21: Proteolytic Systems

Inhibition of prostate cancer cell invasion by targeting the different domains of membrane type 1-matrix metalloproteinase (MT1-MMP)

Jian Cao, Pallavi Kozarekar and Christian Chiarelli
Jian Cao
SUNY at Stony Brook, Stony Brook, NY and VA Medical Center, Northport, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pallavi Kozarekar
SUNY at Stony Brook, Stony Brook, NY and VA Medical Center, Northport, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Chiarelli
SUNY at Stony Brook, Stony Brook, NY and VA Medical Center, Northport, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2005
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 46, 2005

Abstract

2957

Extracellular matrix (ECM) degradation and cell migration are key steps for initiation of malignant cell invasion and metastasis. MT1-MMP has been linked with those processes by digesting ECM components and promoting cell migration. We recently demonstrated that the catalytic domain and hemopexin (PEX) domain of MT1-MMP play a distinct role in terms of substrate degradation and cell migration, respectively (Cao et al. J. Biol. Chem., 2004). By employing a three-dimensional (3D) culture system and cancer cell lines stably expressing MT1-MMP-Green Fluorescent Protein chimera (MT1-GFP) or GFP control, we now present evidence that MT1-MMP induces cancer cell scattering in 3D type I collagen matrices and this cell growth pattern is completely abolished by inhibiting either the catalytic domain or the PEX domain of MT1-MMP. LNCaP human prostate cancer cells stably transfected with MT1-GFP chimeric cDNA presented a scattering growth pattern in 3D type I collagen matrices as compared with spherical aggregates of LNCaP cells expressing GFP control. Inhibition of enzymatic activity of MT1-MMP by the synthetic hydroxamate inhibitor (CT1748) or TIMP-2, but not TIMP-1 interfered with MT1-MMP-induced cell scattering resulting in formation of cell aggregates. Cells expressing constitutively inactive MT1-MMP (MT1E240-A-GFP chimera) behaved like GFP-expressing cells emphasizing the essential role of enzymatic activity of MT1-MMP in cancer cell invasion. We previously demonstrated that an antibody against the PEX domain of MT1-MMP efficiently blocked MT1-MMP-induced LNCaP cell migration in 2D culture system. To evaluate the effect of the inhibitory antibody on MT1-MMP-induced cell scattering in the 3D collagen type I matrices, the antibody was added into the test system. Cell scattering induced by MT1-MMP was inhibited by the antibody against the PEX domain of MT1-MMP. The same inhibitory effect targeting either the catalytic domain or the PEX domain of MT1-MMP was found with human breast cancer MCF-7 cells stably transfected with MT1-GFP chimeric cDNA. Taken together, our data emphasize that ECM degradation and cell migration are critical aspects for MT1-MMP-induced cancer cell invasion. Targeting either the catalytic core structure or the PEX domain of MT1-MMP will result in interference with MT1-MMP-induced cancer cell invasion.

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 65 (9 Supplement)
May 2005
Volume 65, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of prostate cancer cell invasion by targeting the different domains of membrane type 1-matrix metalloproteinase (MT1-MMP)
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Inhibition of prostate cancer cell invasion by targeting the different domains of membrane type 1-matrix metalloproteinase (MT1-MMP)
Jian Cao, Pallavi Kozarekar and Christian Chiarelli
Cancer Res May 1 2005 (65) (9 Supplement) 694;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Inhibition of prostate cancer cell invasion by targeting the different domains of membrane type 1-matrix metalloproteinase (MT1-MMP)
Jian Cao, Pallavi Kozarekar and Christian Chiarelli
Cancer Res May 1 2005 (65) (9 Supplement) 694;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • CD44-mediated transcriptional regulation of matrix metalloproteinases in breast carcinoma cells involves the CD44 cytoplasmic tail
  • Matrilysin mediates lysophosphatidic acid (LPA)-induced epithelial ovarian cancer (EOC) in vitro invasion
  • Inhibition of invasion in head and neck squamous cell carcinoma by the novel serine proteinase inhibitor headpin
Show more Tumor Biology 21: Proteolytic Systems
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement